PIK-75 Hydrochloride [372196-77-5]
P3540
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePIK-75 Hydrochloride [372196-77-5]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatSoluble in DMSO(4mg/mL), DMF; Water Insoluble; Ethanol Insoluble
- Scientific Descriptionp110alfa PI3K inhibitor.; PIK-75 HCl
- Storage Instruction-20°C
- UNSPSC12352200
References
- Buchanan CM, Dickson JM, Lee WJ, et al. Oncogenic mutations of p110alfa isoform of PI 3-kinase upregulate its protein kinase activity. PLoS One. 2013 Aug 1;8(8):e71337. PMID: 23936502. Aoyagi K, Ohara-Imaizumi M, Nishiwaki C, et al. Acute inhibition of PI3K-PDK1-Akt pathway potentiates insulin secretion through upregulation of newcomer granule fusions in pancreatic bèta-cells. PLoS One. 2012;7(10):e47381. PMID: 23077605. Smirnova T, Zhou ZN, Flinn RJ, et al. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene. 2012 Feb 9;31(6):706-15. PMID: 21725367. Dagia NM, Agarwal G, Kamath DV, et al. A preferential p110alpha/gamma PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-kappaB-dependent manner. Am J Physiol Cell Physiol. 2010 Apr;298(4):C929-41. PMID: 20089935.